|Bid||1.1300 x 0|
|Ask||1.1600 x 0|
|Day's range||1.1250 - 1.1350|
|52-week range||0.8700 - 1.6620|
|Beta (3Y monthly)||0.55|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||1.44|
While Starpharma Holdings Limited (ASX:SPL) shareholders are probably generally happy, the stock hasn't had...
The Starpharma Holdings Limited (ASX:SPL) share price has raced 6% higher following a positive update on its ongoing clinical trials...
The Starpharma Ltd (ASX: SPL) share price jumped in early trade after the company provided an update on its phase 1/2 clinical colorectal cancer drug trial.
In 2006 Jackie Fairley was appointed CEO of Starpharma Holdings Limited (ASX:SPL). This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we'll consider...
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share prices Read More...